

| Emu Oil and Pain Reduction for Diabetic Neuropathy ( Emu Oil is made up of a heavy concentration of essential fatty acids ) Emu oil is made up of omega 3, 6 & 9 fatty acids. Diabetic Neuropathy & Essential Fatty Acids No human being can live without essential fatty acids, but the body cannot produce these important fatty acids. The only way the body can obtain these fatty acids is through diet. A deficiency in essential fatty acids metabolism has been widely reported in both human and animal diabetes. Diabetes impairs essential fatty acid metabolism. Nerve blood flow can be affected and can affect the sciatic nerve. By diet and through topical application of fatty acids people suffering with pain symptoms of diabetic neuropathy have found improvement in circulation and relief of the pain. Those individuals who keep a close watch on their sugar levels and stay on a controlled diet have found even greater results by improved circulation and dealing with nerve damage that can be caused by diabetes by using essential fatty acids. REFERENCE: Dines KC, Cotter MA, Cameron NE: Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia36 :1132 –1138,1993[Medline] Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes46 (Suppl. 2) :S31 –S37,1997[Medline] Stevens MJ, Feldman EL, Greene DA: The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med12 :566 –579,1995[Medline] Sima AAF, Sugimoto K: Experimental diabetic neuropathy: an update. Diabetologia42 :773 –788,1999[Medline] Horrobin DF: The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids31 :181 –197,1988[Medline] Ruiz-Gutierrez V, Stiefel P, Villar J, Garcia-Donas MA, Acosta D, Carneado J: Cell membrane fatty acid composition in type 1 (insulin-dependent) diabetic patients: relationship with sodium transport abnormalities and metabolic control. Diabetologia36 :850 –856,1993[Medline] Huang YS, Horrobin DF, Manku MS, Mitchell J, Ryan MA: Tissue phospholipid fatty acid composition in the diabetic rat. Lipids19 :367 –370,1984[Medline] Chattopadhyay J, Thompson EW, Schmid HH: Nonesterified fatty acids in normal and diabetic rat sciatic nerve. Lipids27 : 513 –517,1992[Medline] Coste T, Pierlovisi M, Leonardi J, Dufayet D, Gerbi A, Lafont H, Vague P, Raccah D: Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic rats. J Nutr Biochem10 :411 –420,1999 Dines KC, Cotter MA, Cameron NE: Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia36 :1132 –1138,1993[Medline] Gerbi A, Maixent JM, Ansaldi JL, Pierlovisi M, Coste T, Pellissier JF, Vague P, Raccah D: Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr129 :207 –213,1999 [Abstract/Free Full Text] Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A: Na,K-ATPase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters. Cell Mol Biol47 :297 –304,2001 Gerbi A, Zerouga M, Debray M, Durand G, Chanez C, Bourre JM: Effect of dietary alpha-linolenic acid on functional characteristic of Na+/K(+)-ATPase isoenzymes in whole brain membranes of weaned rats. Biochim Biophys Acta1165 : 291 –298,1993[Medline] Gerbi A, Maixent JM: Fatty acid-induced modulation of ouabain responsiveness of rat Na,K-ATPase isoforms. J Membr Biol168 :19 –27,1999[Medline] Raccah D, Lamotte-Jannot MF, Issautier T, Vague P: Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney. Diabetes Metab20 :271 –274,1994 Raccah D, Fabreguettes C, Azulay JP, Vague P: Erythrocyte Na+-K+-ATPase activity, metabolic control, and neuropathy in IDDM patients. Diabetes Care19 :564 –568,1996[Abstract] Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G: Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci120 :159 –167,1993[Medline] Gerbi A, Barbey O, Raccah D, Coste T, Jamme I, Nouvelot A, Ouafik L, Levy S, Vague P, Maixent JM: Alteration of Na,K- ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia40 :496 –505,1997[Medline] Hammes HP, Weiss A, Furher D, Kamer HJ, Papavassilis C, Grimminger F: Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids. Diabetologia39 :251 –255,1996[Medline] Song JH, Inoue Y, Miyazawa T: Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols, and ethyl esters. Biosci Biotechnol Biochem61 :2085 –2088,1997[Medline] Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA: Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia36 :608 –614,1993 [Medline] Yasuda H, Sonobe M, Yamashita M, Terada M, Hatanaka I, Huitian Z, Shigeta Y: Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes38 :832 –838,1989[Abstract] Beutler E, West C, Blume KG: The removal of leukocytes and platelets from whole blood. J Lab Clin Med88 :328 –333,1976[Medline] Raccah D, Gallice P, Pouget J, Vague P: Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabetes Metab18 :236 –241,1992 Hurst RO: The determination of nucleotide phosphorus with a stannous chloride hydrazine sulphate reagent. Can J Biochem42 :287 –292,1964 Bligh EG, Dyer WY: A rapid method of total lipid extraction and purification. Can J Biochem Physiol37 :911 –917,1959 Ohta A, Mayo MC, Kramer N, Lands WE: Rapid analysis of fatty acids in plasma lipids. Lipids25 :742 –747,1990[Medline] Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC: Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. J Diabetes Complications12 :154 –162,1998[Medline] Wright RA, Nukada H: Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain117 :1395 –1407,1994[Abstract] Das PK, Bray GM, Aguayo AJ, Rasminsky M: Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol53 :285 –288,1976[Medline] Greene DA, Lattimer SA, Sima AA: Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy. Diabetes37 :688 –693,1988[Abstract] Kowluru R, Bitensky MW, Kowluru A, Dembo M, Keaton PA, Buican T: Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc Natl Acad Sci U S A86 :3327 –3331,1989[Abstract] Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA: Slowing of motor nerve conduction velocity in streptozotocin- induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res1 :131 –143,2000[Medline] Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA: Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci U S A88 :6107 –6111,1991 [Abstract] Zochodne DW: Diabetic neuropathies: features and mechanisms. Brain Pathol9 :369 –391,1999[Medline] Cameron NE, Cotter MA, Low PA: Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol261 :E1 –E8,1991[Medline] Stevens EJ, Carrington AL, Tomlinson DR: Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia37 :43 –48,1994[Medline] Ido Y, Chang K, Lejeune W, Tilton RG, Monafo WW, Williamson JR: Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy. Am J Physiol273 :E174 –E184,1997[Medline] Theriault M, Dort J, Sutherland G, Zochodne DW: Local human sural nerve blood flow in diabetic and other polyneuropathies. Brain120 :1131 –1138,1997[Abstract] Forst T, De La Tour DD, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J, Vague P: Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci98 :283 –290,2000[Medline] Pöschl JM, Leray C, Groscolas R, Ruef P, Linderkamp O: Dietary docosahexaenoic acid improves red blood cell deformability in rats. Thromb Res81 :283 –288,1996[Medline] Lands WE: Biochemistry and physiology of n-3 fatty acids. FASEB J6 :2530 –2536,1992[Abstract/Free Full Text] Holman RT, Johnson SB, Gerrard JM, Mauer SM, Kupcho-Sandberg S, Brown DM: Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci U S A80 :2375 –2379,1983[Abstract] Zhu X, Eichberg J: A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A87 :9818 –9822,1990[Abstract] Gerbi A, Maixent JM, Barbey O, Jamme I, Pierlovisi M, Coste T, Pieroni G, Nouvelot A, Vague P, Raccah D: Alterations of Na,K-ATPase isoenzymes in the diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids. J Neurochem71 :732 –740,1998[Medline] Dyck PJ, Karnes JL, Lais A, Lofgren EP, Stevens JC: Pathological alterations of the peripheral nervous system of human. In Peripheral Neuropathy. Dyck P, Thomas P, Lambert E, Bunge R, Eds. Philadelphia, WB Saunders, 1984, p. 760–870 Diagne A, Fauvel J, Record M, Chap H, Douste-Blazy L: Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim Biophys Acta793 :221 –231,1984[Medline] Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ: Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res42 :1987 –1995,2001 [Abstract/Free Full Text] Lazarow PB: The role of peroxisomes in mammalian cellular metabolism. J Inherit Metab Dis10 (Suppl. 1) :11 –22,1987 Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev20 :649 –688,1999[Abstract/Free Full Text] Horrocks LA, Yeo YK: Health benefits of docosahexaenoic acid (DHA). Pharmacol Res40 :211 –225,1999[Medline] Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ: Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes51 :2227 –2232,2002[Abstract/Free Full Text] |
